ReviewBiologics : targets & therapy2017

Octreotide long-acting repeatable in the treatment of neuroendocrine tumors: patient selection and perspectives.

Hanford Yau et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.